Back
Protagonist Therapeutics Stock Predictions
Sponsored
PTGX
Sponsored
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Sell
50
PTGX
Protagonist Therapeutics
Last Price:
25.11
Seasonality Move:
25.26%
7 Day Trial
ALL ACCESS PASS
$
7
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftlyProtagonist Therapeutics Stock Forecast
- Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 41.7% based on the past 7 years of stock performance.
- Protagonist Therapeutics has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
-
Is Protagonist Therapeutics Stock Undervalued?
The current Protagonist Therapeutics [PTGX] share price is $25.15. The Score for PTGX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal. - PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Protagonist Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 41.7% based on the past 7 years of stock performance.
Protagonist Therapeutics Stock Rating
Sell
50
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics overpriced?
- Protagonist Therapeutics has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Protagonist Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protagonist-inc.com
52-Week Data
52-Week High:
33.34
52-Week Low:
13.72
Prediction Charts
Market Cap:
1.47B
Price in USD:
25.15
Volume:
375K
Beta:
2.07
Technical Analysis
SMA50:
28.30
SMA100:
25.99
SMA200:
21.81
52-Wk Change:
8.13%
Stock Predictions
-
Is Protagonist Therapeutics stock public?
Yes, Protagonist Therapeutics is a publicly traded company. -
What is the Protagonist Therapeutics stock quote today?
The Protagonist Therapeutics stock price is 25.15 USD today. -
How to buy Protagonist Therapeutics stock online?
You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-9 | 28.15 | 29.16 | 29.21 | 27.94 |
Apr-10 | 28.22 | 27.86 | 28.54 | 27.74 |
Apr-11 | 28.20 | 27.69 | 28.40 | 27.37 |
Apr-12 | 27.52 | 27.04 | 27.57 | 26.66 |
Apr-15 | 27.18 | 26.59 | 27.35 | 26.32 |
Apr-16 | 26.30 | 26.08 | 26.40 | 25.93 |
Apr-17 | 26.39 | 25.56 | 26.39 | 25.35 |
Apr-18 | 25.34 | 25.22 | 25.76 | 25.17 |
Apr-19 | 25.11 | 25.62 | 25.63 | 24.79 |
Apr-22 | 25.84 | 26.63 | 26.99 | 25.71 |
Apr-23 | 26.65 | 26.82 | 27.78 | 26.61 |
Apr-24 | 26.92 | 25.70 | 27.61 | 25.59 |
Apr-25 | 25.13 | 24.66 | 25.35 | 24.51 |
Apr-26 | 24.61 | 25.15 | 25.23 | 24.22 |
Protagonist Therapeutics Earnings
Protagonist Therapeutics Earnings Report: Per Share Protagonist Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Protagonist Therapeutics Forecast Revenue Growth
Protagonist Therapeutics Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.23 per share.
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.